By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Epigenomics this week said that has launched a study of its Epi proColon test to examine adoption patterns in the market.

The German molecular diagnostics firm launched the colorectal cancer test in Europe in 2009. It is currently being marketed by Epigenomics to privately insured individuals and self-payors in Germany, Austria, and Switzerland and through distributors in other markets, the firm said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.